LSE:AZN (AstraZeneca PLC)
About AZN
AstraZeneca is a biopharmaceutical business that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three main therapy areas - Respiratory, Inflammation and Autoimmunity (RIA), Cardiovascular and Metabolic Disease (CVMD) and Oncology – as well as in Infection and Neuroscience.
AstraZeneca PLC (LSE: AZN) Latest News

Investing Articles
Best British shares to buy in November

Investing Articles
What on earth is going on with the AstraZeneca share price?

Investing Articles
6 super investors hold this FTSE 100 stock. Should I buy it too?

Investing Articles
Down 10%, the most valuable stock on the FTSE 100 is starting to look cheap!

Investing Articles
2 FTSE 100 shares to buy in the UK stock market crash

Investing Articles
2 no-brainer value stocks I think I’ll buy for Q4

Investing Articles
If I’d invested £1,000 in AstraZeneca shares at the start of 2022, here’s what I’d have now

Investing Articles
1 FTSE 100 stock that should continue to outperform long term

Page
Investing in Blue-Chip Companies: Top UK Blue-Chip Stocks in 2022

Investing Articles
Is this FTSE 100 pharma giant a growth stock in disguise?

Page
Investing in Healthcare: Top UK Healthcare Stocks in 2022
